Skip to main content
CHE logo

CHE · Chemed Corp · Webcasts, Transcripts & Audio

Track CHE — free
Market Cap
$7.12B
Shares
13.01M
Volume · Nov 19 24.83K Avg daily vol (3M) 151.72K

Chemed Corp Webcasts

Earnings calls, investor updates, investor days and conferences for Chemed Corp (CHE), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-11-09
Chemed Corp (CHE) November 9, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-10-28
Chemed Corp (CHE) Q3 2026 Earnings Call Transcript
Confident tone Roto-Rooter marketing and lead-generation costs VITAS growth and strong financial performance Roto-Rooter organic growth and margin recovery
Revenue
$690.94M
▲ 10.6% YoY
Diluted EPS
$5.45
▲ 22.2% YoY
Gross margin
33.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-15
Chemed Corp (CHE) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-29
Chemed Corp (CHE) Q2 2026 Earnings Call Transcript
Confident tone VITAS hospice admissions growth Florida Medicare cap position Roto-Rooter commercial business
Revenue
$673.25M
▲ 8.8% YoY
Diluted EPS
$5.13
▲ 43.7% YoY
Gross margin
32.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-05-20
Chemed Corp (CHE) May 20, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-12
Chemed Corp (CHE) May 12, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-24
Chemed Corp (CHE) Q1 2026 Earnings Call Transcript
Confident tone VITAS admissions and patient mix VITAS regulatory and fraud concerns Florida Medicare cap position
Revenue
$657.51M
▲ 1.6% YoY
Diluted EPS
$4.84
▼ 0.4% YoY
Gross margin
32.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Chemed Corp (CHE) Q4 2025 Earnings Call Transcript
Positive tone Paid vs. natural search leads VITAS admissions mix rebalancing Water restoration billing and collections
Revenue
$639.34M*
▼ 0.1% YoY
Gross margin
34.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-29
Chemed Corp (CHE) Q3 2025 Earnings Call Transcript
Positive tone VITAS Medicare Cap mitigation Lead generation mix shift VITAS admissions and census growth
Revenue
$624.90M
▲ 3.1% YoY
Diluted EPS
$4.46
▼ 10.8% YoY
Gross margin
32.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
Chemed Corp (CHE) Q2 2025 Earnings Call Transcript
Cautious tone VITAS Medicare cap / Florida billing limitation VITAS admissions and patient mix Roto-Rooter competition and marketing
Revenue
$618.80M
▲ 3.8% YoY
Diluted EPS
$3.57
▼ 23.2% YoY
Gross margin
29.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-23
Chemed Corp (CHE) Q1 2025 Earnings Call Transcript
Confident tone VITAS operating performance and growth Roto Rooter revenue and margin trends Medicare cap management
Revenue
$646.94M
▲ 9.8% YoY
Diluted EPS
$4.86
▲ 14.6% YoY
Gross margin
33.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
Chemed Corp (CHE) Q4 2024 Earnings Call Transcript
Positive tone VITAS Healthcare operations 2025 financial guidance Medicare cap limitations
Revenue
$639.99M*
▲ 9.2% YoY
Gross margin
36.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-29
Chemed Corp (CHE) Q3 2024 Earnings Call Transcript
Balanced tone Roto-Rooter revenue decline VITAS Healthcare strong performance 2025 outlook and guidance
Revenue
$606.18M
▲ 7.4% YoY
Diluted EPS
$5.00
▲ 1.4% YoY
Gross margin
34.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-24
Chemed Corp (CHE) Q2 2024 Earnings Call Transcript
Confident tone Covenant Health Acquisition VITAS Hospice Operating Strength Florida Market Expansion (CON)
Revenue
$595.88M
▲ 7.6% YoY
Diluted EPS
$4.65
▲ 32.5% YoY
Gross margin
34.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-24
Chemed Corp (CHE) Q1 2024 Earnings Call Transcript
Positive tone VITAS admissions and census growth VITAS hiring and retention Covenant Health and Community Services acquisition
Revenue
$589.23M
▲ 5.2% YoY
Diluted EPS
$4.24
▲ 18.4% YoY
Gross margin
34.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Chemed Corp (CHE) Q4 2023 Earnings Call Transcript
Positive tone 2024 guidance and margin outlook VITAS operational improvement and ADC growth Medicare reimbursement dynamics
Revenue
$585.91M*
▲ 7.2% YoY
Gross margin
38.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-25
Chemed Corp (CHE) Q3 2023 Earnings Call Transcript
Revenue
$564.53M
▲ 7.2% YoY
Diluted EPS
$4.93
▲ 30.4% YoY
Gross margin
35.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
Chemed Corp (CHE) Q2 2023 Earnings Call Transcript
Revenue
$553.82M
▲ 4.2% YoY
Diluted EPS
$3.51
▼ 20.2% YoY
Gross margin
32.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-26
Chemed Corp (CHE) Q1 2023 Earnings Call Transcript
Revenue
$560.16M
▲ 5.6% YoY
Diluted EPS
$3.58
▼ 15.2% YoY
Gross margin
33.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Chemed Corp (CHE) Q4 2022 Earnings Call Transcript
Revenue
$546.65M*
▲ 1% YoY
Gross margin
36.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-31
Chemed Corp (CHE) Q3 2022 Earnings Call Transcript
Revenue
$526.47M
▼ 2.3% YoY
Diluted EPS
$3.78
▼ 16.9% YoY
Gross margin
34.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-27
Chemed Corp (CHE) Q2 2022 Earnings Call Transcript
Revenue
$531.29M
▼ 0.2% YoY
Diluted EPS
$4.40
▲ 25.4% YoY
Gross margin
36.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-26
Chemed Corp (CHE) Q1 2022 Earnings Call Transcript
Revenue
$530.55M
▲ 0.6% YoY
Diluted EPS
$4.22
▲ 5.2% YoY
Gross margin
36.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Chemed Corp (CHE) Q4 2021 Earnings Call Transcript
Revenue
$540.98M*
▲ 1.4% YoY
Gross margin
37.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Chemed Corp (CHE) Q3 2021 Earnings Call Transcript
Revenue
$538.67M
▲ 2% YoY
Diluted EPS
$4.55
▲ 9.9% YoY
Gross margin
36.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-27
Chemed Corp (CHE) Q2 2021 Earnings Call Transcript
Revenue
$532.26M
▲ 6% YoY
Diluted EPS
$3.51
▼ 29.9% YoY
Gross margin
34.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-27
Chemed Corp (CHE) Q1 2021 Earnings Call Transcript
Revenue
$527.36M
▲ 2.2% YoY
Diluted EPS
$4.01
▲ 18.6% YoY
Gross margin
35.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-23
Chemed Corp (CHE) Q4 2020 Earnings Call Transcript
Revenue
$533.29M*
▲ 2.1% YoY
Gross margin
37.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Chemed Corp (CHE) Q3 2020 Earnings Call Transcript
Revenue
$528.30M
▲ 9.9% YoY
Diluted EPS
$4.14
▲ 16.3% YoY
Gross margin
35.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Chemed Corp (CHE) Q2 2020 Earnings Call Transcript
Revenue
$502.20M
▲ 6% YoY
Diluted EPS
$5.01
▲ 62.7% YoY
Gross margin
29.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-28
Chemed Corp (CHE) Q1 2020 Earnings Call Transcript
Revenue
$515.80M
▲ 11.6% YoY
Diluted EPS
$3.38
▲ 25.2% YoY
Gross margin
31.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-18
Chemed Corp (CHE) Q4 2019 Earnings Call
Revenue
$522.32M*
▲ 14.2% YoY
Gross margin
33.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–32 of 32 webcasts
Key facts CIK 19584 CUSIP 16359R103 13F (30d) 559 filings 500 filers Visit website Investor relations